At LCS Medical Spa, we understand that significant weight lossespecially with medications like Ozempicis a major accomplishment for your health and well-being
A 2022 review of 63 papers and scientific presentations also found weak evidence to support this diet (Barkell and Genc 2022)
It works by activating two receptors simultaneously, GLP-1 and GIP, which is why its appetite suppression tends to be more pronounced than single-receptor GLP-1 medications for many patients
Acute Gallbladder Disease In clinical trials of ZEPBOUND, cholelithiasis was reported in 1.1% of ZEPBOUND-treated patients and 1% of placebo-treated patients, cholecystitis was reported in 0.7% of ZEPBOUND-treated patients and 0.2% of placebo-treated patients, and cholecystectomy was reported in 0.2% of ZEPBOUND-treated patients and no placebo-treated patients
Chen B, Yu X, Horvath-Diano C, Ortuo MJ, Tschp MH, Jastreboff AM, Schneeberger M (2024) GLP-1 programs the neurovascular landscape
If you developed gastroparesis after using Ozempic, you may have a legal claim